About this trial
The ultrasound-guided retroclavicular approach to the infraclavicular region (RAPTIR) brachial plexus block has gained popularity as a relatively easy-to-perform nerve block that provides reliable and dense anesthesia to the upper extremity with a single injection. The block has been well described in the anesthesia community since it was first introduced by Hebbard and Royse in 2007 . In 2017, Luftig first described the block's use in the ED setting for a variety of indications . This nerve block has classically been described to provide extensive anesthesia for procedures distal to the shoulder, such as elbow dislocations, distal radius fractures, and surgical procedures.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing upper limb orthopedic surgery,
Disqualifiers
- Contraindications to regional block (coagulopathy, infection at the needle insertion site, or diaphragmatic paralysis).
Altered conscious level.
Pregnancy.
Body mass index (BMI > 35).
Trial design
Parallel
Treatments tested in this trial
retrocalvicular block
Other interventionretrocalvicular block in upper limb orthopedic Surgey
Treatment groups
Trial outcomes
Primary outcomes
numerical rating pain scale .
0= no pain , 10 = sever pain
Sponsors and contacts
Click on the lead sponsor to view all of their trials.